Literature DB >> 16628240

Retinal diseases in Ibadan.

T S Oluleye, A I Ajaiyeoba.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16628240     DOI： 10.1038/sj.eye.6702343

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  8 in total

1.  Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review.

Authors:  Okechukwu S Ogah; Ikechi Okpechi; Innocent I Chukwuonye; Joshua O Akinyemi; Basden Jc Onwubere; Ayodele O Falase; Simon Stewart; Karen Sliwa
Journal:  World J Cardiol       Date:  2012-12-26

2.  Etiology of visual impairment among ophthalmic patients at Federal Medical Center, Abeokuta, Nigeria.

Authors:  Oo Sijuwola; O Fasina
Journal:  J West Afr Coll Surg       Date:  2012-10

3.  RETINAL DISEASES IN A TERTIARY HOSPITAL IN SOUTHERN NIGERIA.

Authors:  O M Uhumwangho; E I Itina
Journal:  J West Afr Coll Surg       Date:  2015 Apr-Jun

4.  Is age-related macular degeneration a problem in Ibadan, Sub-Saharan Africa?

Authors:  Tunji Sunday Oluleye
Journal:  Clin Ophthalmol       Date:  2012-04-11

Review 5.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

6.  Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria.

Authors:  Oluseyi Adejumo; Enajite Okaka; Ikponmwosa Iyawe
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

7.  Visual Outcome of Anti-vascular Endothelial Growth Factor Injections at the University College Hospital, Ibadan.

Authors:  Tunji Sunday Oluleye; Yewande Olubunmi Babalola; Oluwole Majekodunmi; Modupe Ijaduola; Adeyemi Timothy Adewole
Journal:  Ann Afr Med       Date:  2021 Oct-Dec

8.  Indications for intravitreal bevacizumab in ibadan, sub-saharan Africa.

Authors:  Oluleye T S; Babalola Y
Journal:  Open Ophthalmol J       Date:  2014-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.